204
Participants
Start Date
August 28, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2026
moderate to deep neuromuscular blockade
"* Maintaining moderate to deep neuromuscular blockade during an intraoperative period (Train-of-four 0-3 count, post-tetanic count \> 1)~* Rocuronium (intravenous, 1.0 mg/kg at induction period)"
shallow to minimal neuromuscular blockade
"* Maintaining shallow to minimal neuromuscular blockade during an intraoperative period (Train-of-four 4, post-tetanic count \< 0.9)~* Rocuronium (intravenous, 0.3 mg/kg at induction period)"
RECRUITING
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER